Cardinal Health, Inc. $CAH Shares Sold by Callahan Advisors LLC

Key Points

• Callahan Advisors LLC reduced its holdings in Cardinal Health, Inc. by 8.4% during the second quarter, selling 4,396 shares and bringing its total to 47,671 shares valued at approximately $8,009,000.
• Major institutional investors, including JPMorgan Chase & Co. and Wellington Management Group LLP, significantly increased their stakes in Cardinal Health during the first quarter, with overall institutional ownership now at 87.17%.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Cardinal Health with a target price averaging $166.00, reflecting optimism in the company's growth potential despite fluctuations in earnings and revenue.

Callahan Advisors LLC trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,671 shares of the company's stock after selling 4,396 shares during the quarter. Callahan Advisors LLC's holdings in Cardinal Health were worth $8,009,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its stake in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after buying an additional 1,193,983 shares during the period. Northern Trust Corp increased its stake in Cardinal Health by 3.5% in the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after buying an additional 105,154 shares during the period. Wellington Management Group LLP increased its stake in Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after buying an additional 2,249,241 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Cardinal Health by 3.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after buying an additional 52,714 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Cardinal Health by 0.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company's stock valued at $171,749,000 after buying an additional 7,940 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on CAH shares. Leerink Partners boosted their price objective on shares of Cardinal Health from $186.00 to $187.00 and gave the company an "outperform" rating in a research note on Monday, October 6th. Weiss Ratings reissued a "buy (b)" rating on shares of Cardinal Health in a research note on Wednesday, October 8th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Evercore ISI lowered their price target on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average target price of $166.00.

Cardinal Health Stock Up 1.0%

NYSE:CAH opened at $155.72 on Thursday. Cardinal Health, Inc. has a fifty-two week low of $106.98 and a fifty-two week high of $168.44. The stock has a market cap of $37.00 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.30 and a beta of 0.71. The firm's fifty day simple moving average is $151.90 and its 200-day simple moving average is $151.48.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business's revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were given a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health's payout ratio is currently 31.63%.

Insiders Place Their Bets

In related news, CEO Jason M. Hollar sold 35,901 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.